Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 2 | |
Outperform | 3 | |
Hold | 1 | |
Sell | 1 | |
Strong Sell | 0 |
Share price forecast in USD
The 6 analysts offering 12 month price targets for Esperion Therapeutics Inc have a median target of 6.50, with a high estimate of 16.00 and a low estimate of 2.05. The median estimate represents a 163.16% increase from the last price of 2.47.
High | 547.8% | 16.00 |
Med | 163.2% | 6.50 |
Low | -17.0% | 2.05 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 25, 2025.
Average growth rate | +9.71% |
Average growth rate | -4.79% |
More ▼
Revenue history & estimates in USD
Average growth rate | +61.39% |
Average growth rate | +9.55% |
More ▼